Prevalence of obesity and cardiovascular risk in patients with HIV/AIDS in porto alegre, Brazil;Prevalência de obesidade e risco cardiovascular em pacientes com HIV/AIDS em porto alegre, Brasil

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 56, Issue 2, 2012, Pages 137-141

  Kroll, Andrea Francis ^a,b   Sprinz, Eduardo ^c   Leal, Suzete Carbonell ^d   Labrêa, Maria da Graça ^b   Setúbal, Sérgio ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Ambulatório de Dermatologia Sanitária de Porto Alegre   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^d Instituto de Administração Hospitalar e Ciências da Saúde IACHS   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Body mass index; HIV; Obesity; Overweight

Indexed keywords

EID: 84861312761     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302012000200007     Document Type: Article

References (28)

1. UNAIDS/World Health Organization. AIDS Epidemic Update: December 2009. Available from: http://data.unAIDS.org/pub/Report/2009/2009_epidemic_update_en.pdf. Access on: Dec 8, 2009.
2. a - semanas epidemiológicas - janeiro a junho de 2009. Available from: http://www2.AIDS.gov.br/sites/default/files/Boletim2010.pdf. Access on: Ago 13, 2010.
3. Coppini LZ, Ferrini MT. Síndrome da imunodeficiência adquirida. In: Cuppari L, editor. Nutrição Clínica no Adulto. São Paulo: Manole; 2005.
4. Sprinz E, Finkelszteijn A. Rotinas de HIV e AIDS. In: Nascimento C, editor. Cuidados nutricionais: avaliação e manejo. Porto Alegre: Artes Médicas; 1999.
5. Araújo PSR, Ximenes RAA, Lopes CFC, Duarte JY, Silva, MM, Carneiro EM. Antiretroviral treatment for HIV infection/AIDS and the risk of developing hyperglycemia and hyperlipidemia. Rev Inst Med Trop. 2007;49(2):73-78.
6. Levy AR, Mccandless L, Harrigan RP, Hogg RS, Bondy G, Iloeje UH, et al. Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS. Lipids Health Dis. 2005;4:1476-1511.
7. Valente AMM, Reis AF, Machado DM, Succi RCM, Chacra AR. Alterações metabólicas da síndrome lipodistrófica do HIV. Arq Bras Endocrinol Metab. 2005;49(6):871-881.
8. a Edición. Madri: Ed. Rosa Pólo; 2002.
9. Galli M, Ridolfo AL, Adorni F, Gervasoni C, Ravasio L, Corsico L, et al. Body habitus changes and metabolic alterations in protease inhibitor-naive HIV-1-infected patients treated with two nucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr. 2002;29(1):21-31.
10. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32(1):130-139.
11. Silva M, Skolnik PR, Gorbach SL, Spiegelman D, Wilson IB, Fernández- Difranco MG, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. Acquir Immune Defic Syndr. 1998;12(13):1645-1651.
12. Miller KD, Jones E, Yanvoski JA, Shankar R, Feuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet. 1998;351(9106):871-875.
13. Amorosa V, Synnestvedt M, Gross R, Friedman H, Macgregor RR, Gudonis D, et al. A table of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr. 2005;39(5):557-561.
14. Kruzich LA, Marquis GS, Wilson CM, Stephensen CB. HIV-infected US youth are at high risk of obesity and poor diet quality: a challenge for improving short-and long-term health outcomes. J Am Diet Assoc. 2004;104(10):1554-1560.
15. Shuter J, Chang CJ, Klein RS. Prevalence and predictive value of overweight in an urban HIV care clinic. Acquir Immune Defic Syndr. 2001;26(3):291-297.
16. Jaime PC, Florindo AA, Latorre MRDO, Brasil BG, Santos ECMD, Segurado AAC. Prevalência de sobrepeso e obesidade abdominal em indivíduos portadores de HIV/AIDS, em uso de terapia anti- retroviral de alta potência. Rev Bras Epidemiol. 2004;7(1):65-72.
17. Leite LHM, Sampaio ABMM. Metabolics abnormalities and overweight in HIV/AIDS persons-treated with antiretroviral therapy. Rev Nutr. 2008;21(3):277-283.
18. Farhi L, Lima DB, Cunha CB. Dyslipidemia in HIV/AIDS patients in antiretroviral therapy in a university hospital, Rio de Janeiro, Brazil. J Bras Patol Med Lab. 2008;44(3):175-184.
19. Fagundes AA. Vigilância alimentar e nutricional - Sisvan: orientações básicas para a coleta, processamento, análise de dados e informação em serviços de saúde. Brasília: Ministério da Saúde; 2004.
20. World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Geneva, Switzerland: WHO, 2008.
21. Hendricks KM, Erzen HD, Wanke CA, Tang AM. Nutrition issues in the HIV-infected injection drug user: findings from the nutrition for healthy living cohort. J Am Coll Nutr. 2010;29(2):136-143.
22. Ministério da Saúde. Pesquisa de Orçamentos Familiares 2008- 2009: antropometria e estado nutricional de crianças, adolescentes e adultos no Brasil. Rio de Janeiro: IBGE; 2010.
23. Lo J, You SM, Wei J, Canavan B, Grinspoon S. Relationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults. Clin Endocrinol (Oxf). 2009;71(6):815-822.
24. De Socio GV, Martinelli C, Ricci E, Orofino G, Valsecchi L, Vitiello P, et al. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study. Int J STD Aids. 2010;21(4):267-272.
25. Oketch JA, Paterson M, Maunder EW, Rollins NC. Too little, too late: comparison of nutritional status and quality of life of nutrition care and support recipient and non-recipients among HIV- -positive adults in KwaZulu-Natal, South Africa. Health Policy. 2011;99(3):267-276.
26. Pao V, Lee GA, Grunfeld C. HIV therapy, metabolic syndrome, and cardiovascular risk. Curr Atheroscler Rep. 2008;10(1):61-70.
27. Ena J, Benito C, Llácer P, Pasquau F, Amador C. Abnormal body fat distribution and type of antiretroviral therapy as predictors of cardiovascular disease risk in HIV-infected patients. Med Clin (Barc). 2004;122(19):721-726.
28. Barros ZM, Ximenes RAA, Miranda-Filho DMB, Albuquerque MFPM, Melo HRL, Carvalho EH, et al. Comparison between the Framingham and prospective cardiovascular of Münster scores for risk assessment of coronary heart disease in human immunodeficiency virus-positive patients in Pernambuco, Brazil. Metab Syndr Relat Disord. 2010;8(6):489-497.